Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lance Heilbrun

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Statistical Methods in Medical Research|March 7, 2015
Sample size determination for logistic regression on a logit-normal distributionSeongho Kim, Elisabeth Heath, Lance Heilbrun
Photochemistry and Photobiology|December 11, 2012
Effects of the oxygenation level on formation of different reactive oxygen species during photodynamic therapyMichael Price, Lance Heilbrun, David Kessel
Clinical Genitourinary Cancer|August 21, 2009
Safety and efficacy of sorafenib therapy in patients with metastatic kidney cancer with impaired renal functionVenkata Parsa, Lance Heilbrun, Daryn Smith, et al.
Abdominal Radiology (New York)|April 7, 2025
Fast prostate MRI vs. conventional multiparametric prostate MRI: comparison and outcomesHamed Kordbacheh, Gorica Ristic, Elisabeth Heath, et al.
Anticancer Research|July 31, 2012
Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinomaKhaldoun Almhanna, Bassel El-Rayes, Seema Sethi, et al.
ISRN Oncology|June 30, 2012
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate CancerShin Ogita, Sheela Tejwani, Lance Heilbrun, et al.
Oncotarget|April 30, 2013
Galectin-3: a possible complementary marker to the PSA blood testVitaly Balan, Yi Wang, Pratima Nangia-Makker, et al.
Avicenna Journal of Medicine|April 17, 2015
Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neckAmmar Sukari, Marwan Al-Hajeili, Mohamed Salem, et al.
Clinical Genitourinary Cancer|March 15, 2018
Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate CancerManish K Thakur, Lance Heilbrun, Kimberlee Dobson, et al.
Urology|September 17, 2015
Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium StudyUlka Vaishampayan, Daniel Shevrin, Mark Stein, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Statistical Methods in Medical Research|March 7, 2015
Sample size determination for logistic regression on a logit-normal distributionSeongho Kim, Elisabeth Heath, Lance Heilbrun
Photochemistry and Photobiology|December 11, 2012
Effects of the oxygenation level on formation of different reactive oxygen species during photodynamic therapyMichael Price, Lance Heilbrun, David Kessel
Clinical Genitourinary Cancer|August 21, 2009
Safety and efficacy of sorafenib therapy in patients with metastatic kidney cancer with impaired renal functionVenkata Parsa, Lance Heilbrun, Daryn Smith, et al.
Abdominal Radiology (New York)|April 7, 2025
Fast prostate MRI vs. conventional multiparametric prostate MRI: comparison and outcomesHamed Kordbacheh, Gorica Ristic, Elisabeth Heath, et al.
Anticancer Research|July 31, 2012
Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinomaKhaldoun Almhanna, Bassel El-Rayes, Seema Sethi, et al.
ISRN Oncology|June 30, 2012
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate CancerShin Ogita, Sheela Tejwani, Lance Heilbrun, et al.
Oncotarget|April 30, 2013
Galectin-3: a possible complementary marker to the PSA blood testVitaly Balan, Yi Wang, Pratima Nangia-Makker, et al.
Avicenna Journal of Medicine|April 17, 2015
Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neckAmmar Sukari, Marwan Al-Hajeili, Mohamed Salem, et al.
Clinical Genitourinary Cancer|March 15, 2018
Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate CancerManish K Thakur, Lance Heilbrun, Kimberlee Dobson, et al.
Urology|September 17, 2015
Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium StudyUlka Vaishampayan, Daniel Shevrin, Mark Stein, et al.
Pageof 2